Zobrazeno 1 - 5
of 5
pro vyhledávání: '"I. V. Lapik"'
Biopharmaceutical Properties of New Mucoadhesive Dosage Form for Eye Degenerative Diseases Treatment
Autor:
M. N. Anurova, E. O. Bakhrushina, I. V. Lapik, A. R. Turaeva, N. B. Demina, B. B. Sysuev, I. I. Krasnyuk
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 3, Pp 41-48 (2023)
Introduction. Degenerative retinal diseases, including glaucoma, are the main cause of vision loss in the adult population. The development and improvement of drug treatment of this group of diseases is an urgent problem.Aim. Study of a new dosage fo
Externí odkaz:
https://doaj.org/article/e365024e8b5f47dc9fd1dbec139fe20a
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 1, Pp 57-66 (2021)
Introduction. Effective delivery of ophthalmic drugs is challenging. The eye has a number of protective systems and physiological barriers, which is why ophthalmic dosage forms have a low bioavailability, usually not exceeding 5 %. Topical drug admin
Externí odkaz:
https://doaj.org/article/6e893748ab894ed299cf8d189d082cb2
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 0, Iss 4, Pp 64-70 (2019)
The article describes the main requirements for ophthalmic gels and presents the study of the rheological properties of ophthalmic gels, registered in the Russian Federation: Korneregel®, Solcoseryl®, Vidisic®, Ophtagel®, Oftan-Timogel®, Systein
Externí odkaz:
https://doaj.org/article/177527655c2242f1950d77a39494d51f
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 0, Iss 3, Pp 30-34 (2019)
Studies of the osmotic activity of emoxypine and dalargine ophthalmic experimental gels samples based on various polymers and also studies of some marketed in Russia ophthalmic gels are presented in the article. Selection of the most promising for fu
Externí odkaz:
https://doaj.org/article/cc1e69487e0849769636760f46da5bb0
Publikováno v:
Bulletin of Experimental Biology and Medicine. 168:349-351
The results of the development of combined eye gel with interferon alpha-2-beta are presented. Experimental samples of the gel based on different gelling agents were prepared and their biotechnological and technological characteristics (the absence o